造血干细胞移植患儿双腔耐高压PICC 导管堵塞的影响因素分析
作者:
作者单位:

作者简介:

女,硕士,副主任护师

通讯作者:

基金项目:

厦门市自然科学基金资助课题(3502Z20227100)


Factors influencing blockage of double-lumen power injectable PICCs in children undergoing hematopoietic stem cell transplantation
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨造血干细胞移植患儿双腔耐高压PICC导管堵塞现状及影响因素,为改进导管护理方案提供依据。方法 回顾性收集296例双腔耐高压PICC导管置管患儿的临床资料,经单因素分析和多因素logistic回归分析明确该类患儿导管堵塞的影响因素。结果 造血干细胞移植患儿双腔耐高压PICC导管堵塞发生率为26.69%,年龄、是否静脉应用环孢素A、导管是否脱出、导管有无瓣膜为该类患儿导管堵塞的主要影响因素(均P<0.05)。结论 造血干细胞移植患儿双腔耐高压PICC导管堵塞发生率较高,应重点关注低龄、静脉应用环孢素A的患儿,同时避免导管脱出,有条件的情况下尽可能使用带瓣膜的双腔耐高压PICC导管,以降低导管堵塞的发生。

    Abstract:

    Objective To investigate the incidence and factors influencing blockage of double-lumen power injectable PICCs in children undergoing hematopoietic stem cell transplantation (HSCT), and to provide references for improving catheter care. Methods Clinical data of 296 children with double-lumen Power PICC were retrospectively collected. The influencing factors of catheter blockage were identified by univariate analysis and multivariate logistic regression. Results The incidence of catheter blockage in this sample was 26.69%. Age, whether intravenous use of cyclosporine A, whether having catheter dislodgement, or whether catheter with valve were factors influencing catheter blockage in children undergoing HSCT (all P<0.05). Conclusion The incidence of blockage of double-lumen Power PICCs in children undergoing HSCT is relatively high. Special attention should be paid to children who are relatively young and who receive intravenous cyclosporine A. Meanwhile, catheter dislodgement should be avoided. If conditions permit, we recommend using double-lumen Power PICC with valve to prevent catheter blockage.

    参考文献
    相似文献
    引证文献
引用本文

李兰,石洁,林丽惠,蔡志云,叶熙君,林玉凤,侯雅真,王雅娇,杨柳.造血干细胞移植患儿双腔耐高压PICC 导管堵塞的影响因素分析[J].护理学杂志,2025,(14):51-54

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2024-12-12
  • 最后修改日期:2025-03-27
  • 录用日期:
  • 在线发布日期: 2025-08-13